• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fischer enjoys record fourth quarter

Article

Record fourth quarter sales and earnings helped Fischer Imagingfinish its 1995 fiscal year with a flourish. The Denver-based x-ray vendor reported fourth-quarter earnings(end-December) of $1.5 million and $23 million in sales, bothcompany records.

Record fourth quarter sales and earnings helped Fischer Imagingfinish its 1995 fiscal year with a flourish.

The Denver-based x-ray vendor reported fourth-quarter earnings(end-December) of $1.5 million and $23 million in sales, bothcompany records. Revenues were up 25% from the same period of1994.

For the 1995 fiscal year, Fischer reported net earnings of$2.3 million on the strength of $76.8 million in sales. The performancewas a notable improvement over fiscal 1994, when the company lost$5.6 million on sales of $68.5 million. CEO Morgan Nields attributedthe turnaround to an improved sales mix and global sales growth,as well as gains made through OEM deals and internal cost-cuttingmeasures.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.